We are willing to cooperate with worldwide biomedical research institutions, companies and academic institutions in multi-directional strategic cooperation, based on our team's leadership and research and development capabilities, with complementary resources, win-win cooperation, to create the international frontier core skeleton oncology pipeline.

We are willing to license-out our independently developed and patented pipelinesby global or regional rights.

We are willing tolicense-in first-in-class or highly differentiated drug candidates from global partners for development and commercialization in the global market.

We are willing to cooperate with the cutting-edge biotechnology professionals to jointly create breakthrough targeted oncology pipelines, and enjoy the benefits for life with a high equity incentive, so as to realize their personal value in cancer therapy field.